Form 483

PENMIX LTD Form 483, 2026-05-29

FDA issued a Form 483 to PENMIX LTD on 2026-05-29 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

PENMIX LTD · Cheonan, Korea (the Republic of) · Issued May 29, 2026

Overview

  • 7 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 May 2026
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Khoa Nathan V Tran

29 May 2026
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Khoa Nathan V Tran

29 May 2026
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Khoa Nathan V Tran

29 May 2026
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Khoa Nathan V Tran

29 May 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Khoa Nathan V Tran

Inspected site

PLPENMIX LTDCheonan, Korea (the Republic of)

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere